<DOC>
	<DOCNO>NCT00208468</DOCNO>
	<brief_summary>This post-market clinical follow-up study design compare hip replacement outcome European Hip 3 control ( Omniflex , Zweymuller , Spotorno ) , however Omniflex end use . The first patient surgery February 18 , 2000 final patient surgery September 2 , 2005 . There 317 subject consent 301 hip replacement surgery ( subject receive : 220 European hip , 33 Zweymuller , 48 Spotorno ) . The study take place three site . Each site use standard device control . The Austrian site enrol 69 European hip 33 Zweymuller hip . 92 European hip 48 Spotorno hip enrol Germany . Finally , site Italy enrol 59 European hip . Although study protocol intend collect DEXA RSA outcome , data collect site include outcome .</brief_summary>
	<brief_title>A Randomised Multi-centre Study Compare Long-term Performance Future Hip 3 Other Implants Primary Total Hip Replacement</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Femoral Fractures</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation , Congenital</mesh_term>
	<mesh_term>Legg-Calve-Perthes Disease</mesh_term>
	<mesh_term>Slipped Capital Femoral Epiphyses</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<criteria>) Administrative The subject able understand study , willing give voluntary , write , informed consent , cooperate assessment procedure geographically able comply postoperative followup regime . ii ) Age The subject 's age 18 75 year inclusive . iii ) Sex Male female subject may recruit study . iv ) Diagnosis Subjects must undergo primary THR surgery noninflammatory degenerative joint disease include osteoarthritis , avascular necrosis , posttraumatic arthritis , fracture neck femur nonunion fracture neck femur , SUFE Perthes disease . v ) Suitability Subjects opinion Investigator consider suitable treatment device involve study . ) Subjects undergoing revision procedure operative hip . ii ) Subjects previous femoral osteotomy operative hip . iii ) Subjects history active sepsis joint . iv ) Subjects diagnosed primary secondary carcinoma last five year ( exclude basal cell carcinoma cervical carcinoma ) . v ) Subjects condition may , opinion Investigator , interfere total hip replacement 's survival outcome , e.g . Paget 's disease , Charcot 's disease . vi ) Subjects psychosocial disorder , opinion Investigator would limit rehabilitation . vii ) Subject 's whose weight &gt; 100kg . viii ) Subjects femoral head necrosis nonoperated side ( RSA DEXA subject ) . ix ) Subjects fracture femur &gt; 6 month old ( RSA DEXA subject ) . x ) Subjects diagnosed ankylose spondylitis ( RSA DEXA subject ) xi ) Subjects know history poor compliance medical treatment .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hip</keyword>
	<keyword>Cementless</keyword>
</DOC>